Herborium Group (HBRM) Stock Price, News & Analysis
Company Description
Herborium Group (OTC Link: HBRM) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $1.1M.
This page collects what Stock Titan holds for HBRM, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Herborium Group (HBRM) stock last closed at $0.0001. At a market capitalization of $1.1M, HBRM is classified as a micro-cap stock with approximately 10.9B shares outstanding.
Latest News
Herborium Group has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include crypto, partnership. View all HBRM news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Herborium Group (HBRM) currently stands at 49 shares, a new position with no short interest reported in the previous period. Since July 2025, short interest has decreased by 83.6%.
Days to Cover History
Days to cover for Herborium Group (HBRM) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
HBRM Company Profile & Sector Positioning
Herborium Group (HBRM) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing HBRM often look at related companies in the same sector, including 4Cable Tv Intern (CATV), New Leaf Venture (NLVVF), Premier Biomedical Inc (BIEI), PLANET BASED FOODS GLOBAL INC (PBFFF), and Target Group Inc (CBDY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HBRM's relative position within its industry.